Wei Zhang

Transplant hepatologist/Assistant professor

Massachusetts General Hospital
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Wei Zhang is an Assistant Professor and transplant hepatologist at Massachusetts General Hospital in the United States. His research primarily focuses on hepatocellular carcinoma, investigating significant disparities in outcomes by race, ethnicity, and sociodemographic factors. Dr. Zhang's work aims to enhance understanding and improve treatment approaches for diverse patient populations in the field of liver disease.

Articles (13)

Year:

2026

Background: Hepatocellular carcinoma (HCC) disproportionately affects racial/ethnic minorities. We evaluated the impact of income and geography on racial/ethnic disparities across the HCC care cascade in the United States. Methods: Using NCI registry data spanning 2000 to 2020, adults with HCC were evaluated to determine race/ethnicity-specific differences in tumor stage at diagnosis, delays and gaps in treatment, and survival. Adjusted regression models evaluated predictors of HCC outcomes. Results: Among 112,389 adults with HCC, cohort characteristics were as follows: 49.8% non-Hispanic White (NHW), 12.0% African American(AA), 20.5% Hispanic, 16.5% Asian/Pacific Islander, and 1.1% American Indian/Alaska Native. Compared with NHW patients, AA patients had lower odds of localized-stage HCC at diagnosis [adjusted odds ratio (aOR), 0.84], lower odds of HCC treatment receipt (aOR, 0.77), greater odds of treatment delays (aOR, 1.12), and significantly greater risk of death [adjusted hazards ratio (aHR), 1.10]. Compared with NHW patients from large metro areas, AA patients from large metro areas had 8% higher mortality risk (aHR, 1.08), whereas AA patients from small–medium metro areas had 17% higher mortality risk (aHR, 1.17; all P < 0.05). Conclusions: Among a population-based cohort of US adults with HCC, significant race/ethnicity-specific disparities across the HCC care continuum were observed. Lower household income and more rural geography among racial/ethnic minorities are also associated with disparities in HCC outcomes, particularly among AA patients. Impact: Our study shows that lower income and less urban/more rural geography among racial/ethnic minorities are also associated with disparities in HCC outcomes, particularly among AA patients with HCC. This contextualizes the complex relationship between sociodemographic factors and HCC outcomes through an intersectional lens.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Background: Strategies to identify patients with early alcohol-associated liver disease (ALD), prior to the development of liver-related decompensated events, and promote alcohol therapy engagement in these patients are urgently needed to stem the rising tide of mortality associated with ALD. Methods: We compared the rate of incident liver-related decompensating events in hospitalized patients with alcohol use disorder (AUD) seen either by an integrated hepatology and addiction care approach or addiction care alone at 2 academic medical centers. Cox proportional hazards regression model and a Kaplan–Meier analysis were used. Findings: An integrated approach of hepatology and addiction care is associated with a reduced likelihood of future liver-related decompensating events in hospitalized patients with AUD. This finding correlated with an increased uptake of medical alcohol therapy and a reduced likelihood of an alcohol-associated readmission. Integrated hepatology and addiction care for hospitalized AUD patients may help reduce the progression of ALD.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Supplementary Table 4 shows the results from the adjusted multivariable logistic regression analyses evaluating for predictors of delays in HCC treatment (≥3 months vs.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (5)

Patricia D. Jones

University of Miami Miller School of Medicine

UNITED STATES
View details

Robert J. Wong

Stanford University School of Medicine

UNITED STATES
View details

Amit G. Singal

-

UNITED STATES
View details

Mandana Khalili

Professor of Medicine

University of California, San Francisco

UNITED STATES
View details

Paulo S. Pinheiro

University of Miami Miller School of Medicine

UNITED STATES
View details